Kevin Eng

Kevin Eng is a highly experienced scientist with a background in various research positions at companies such as Stanford Blood Center, Apton Biosystems, Gilead Sciences, and Pacific Biosciences. Kevin's expertise lies in the development of library preparation and next-generation sequencing technologies. Kevin also has experience in designing experiments and conducting research in fields such as monoclonal antibody production, protein expression, and lung cancer tissue analysis.Overall, Kevin has a diverse skill set in biological research and a strong educational background in physical therapy, health science, and biology.